Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DABIGATRAN ETEXILATE Cause Headache? 415 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 415 reports of Headache have been filed in association with DABIGATRAN ETEXILATE (dabigatran etexilate). This represents 1.1% of all adverse event reports for DABIGATRAN ETEXILATE.

415
Reports of Headache with DABIGATRAN ETEXILATE
1.1%
of all DABIGATRAN ETEXILATE reports
35
Deaths
188
Hospitalizations

How Dangerous Is Headache From DABIGATRAN ETEXILATE?

Of the 415 reports, 35 (8.4%) resulted in death, 188 (45.3%) required hospitalization, and 30 (7.2%) were considered life-threatening.

Is Headache Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DABIGATRAN ETEXILATE. However, 415 reports have been filed with the FAERS database.

What Other Side Effects Does DABIGATRAN ETEXILATE Cause?

Gastrointestinal haemorrhage (4,081) Cerebrovascular accident (2,175) Fall (1,786) Ischaemic stroke (1,581) Anaemia (1,412) Haemorrhage (1,324) Death (1,025) Rectal haemorrhage (964) Cerebral haemorrhage (946) Upper gastrointestinal haemorrhage (861)

What Other Drugs Cause Headache?

ADALIMUMAB (19,891) APREMILAST (17,024) ETANERCEPT (14,253) TREPROSTINIL (14,051) METHOTREXATE (11,718) TOFACITINIB (11,061) RITUXIMAB (8,747) TOCILIZUMAB (8,448) INFLIXIMAB (8,387) ABATACEPT (8,184)

Which DABIGATRAN ETEXILATE Alternatives Have Lower Headache Risk?

DABIGATRAN ETEXILATE vs DABRAFENIB DABIGATRAN ETEXILATE vs DABRAFENIB\TRAMETINIB DABIGATRAN ETEXILATE vs DACARBAZINE DABIGATRAN ETEXILATE vs DACLATASVIR DABIGATRAN ETEXILATE vs DACLIZUMAB

Related Pages

DABIGATRAN ETEXILATE Full Profile All Headache Reports All Drugs Causing Headache DABIGATRAN ETEXILATE Demographics